subject: CHEBI:64153

object_name: Mantle cell lymphoma stage III


subject: CHEBI:64153

subject_name: Tanespimycin

object_name: Stage IV Adult Lymphoblastic Lymphoma

tested_intervention: unsure


subject: CHEBI:64153

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: CHEBI:64153

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:64153

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:64153

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:64153

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:64153

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:64153

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: CHEBI:64153

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:64153

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:64153

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:64153

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:64153

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:64153

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:64153

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:64153

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:64153

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:64153

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: CHEBI:64153

object_name: Marginal zone lymphoma stage III


subject: CHEBI:64153

object_name: Stage III Adult Burkitt Lymphoma


subject: CHEBI:64153

object_name: Stage III Adult Hodgkin Lymphoma


subject: CHEBI:64153

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:64153

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:64153

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:64153

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:64153


subject: CHEBI:64153

object_name: Cutaneous T-cell lymphoma stage IV


subject: CHEBI:64153

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:64153

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:64153

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:64153

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:64153

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:64153

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:64153

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: CHEBI:64153

object_name: Adult T-cell lymphoma/leukaemia stage III


subject: CHEBI:64153

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: CHEBI:93755

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:93755

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:93755

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:93755

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:93755

object_name: Mantle cell lymphoma stage III


subject: CHEBI:93755

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:93755

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: CHEBI:93755

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:93755

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:93755

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:93755

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:93755

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:93755

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: CHEBI:93755

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:93755

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:93755

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:93755

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:93755

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:93755

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:93755

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:93755

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:93755

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:93755

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: CHEBI:93755

object_name: Marginal zone lymphoma stage III


subject: CHEBI:93755

object_name: Stage III Adult Burkitt Lymphoma


subject: CHEBI:93755

object_name: Stage III Adult Hodgkin Lymphoma


subject: CHEBI:93755

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:93755

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:93755

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:93755

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:93755


subject: CHEBI:93755

object_name: Cutaneous T-cell lymphoma stage IV


subject: CHEBI:93755

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:93755

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:93755

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:93755

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:93755

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:93755

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:93755

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: CHEBI:93755

object_name: Adult T-cell lymphoma/leukaemia stage III


subject: CHEBI:93755

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: CHEBI:50730

subject_name: Montelukast

object_name: brain neoplasm

tested_intervention: yes


subject: CHEBI:50730

object_name: endometrial cancer


subject: CHEBI:50730

object_name: uterine corpus cancer


subject: CHEBI:50730

object_name: endometrial carcinoma


subject: CHEBI:50730

object_name: malignant soft tissue neoplasm


subject: CHEBI:50730

object_name: sarcoma


subject: CHEBI:50730

object_name: ovarian cancer


subject: CHEBI:50730

object_name: ovarian neoplasm


subject: CHEBI:50730

object_name: ovarian carcinoma


subject: CHEBI:50730

object_name: colorectal cancer


subject: CHEBI:50730

object_name: colorectal carcinoma


subject: CHEBI:50730

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: MESH:D011054

subject_name: Poliovirus Vaccine, Inactivated


subject: UNII:G6UF363ECX

object_name: Metastatic castration-resistant prostate cancer


subject: UNII:G6UF363ECX

object_name: prostate carcinoma


subject: UNII:G6UF363ECX

object_name: metastatic prostate carcinoma


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: Zinc deficiency


subject: UMLS:C2348288

object_name: Child Nutrition Disorders


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:29105


subject: CHEBI:27363

subject_name: Zinc


subject: CHEBI:27363


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3541396


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C3714650


subject: CHEBI:4717

subject_name: Droperidol

object_name: Vomiting, CTCAE


subject: CHEBI:4717

object_name: Vomiting


subject: CHEBI:132767

subject_name: Ferric pyrophosphate

object_name: end stage renal failure


subject: CHEBI:132767

object_name: Chronic uremia


subject: CHEBI:91432

subject_name: Brivanib


subject: CHEBI:91432


subject: CHEBI:91432


subject: CHEBI:91432

object_name: colorectal adenocarcinoma


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: neuronitis


subject: UMLS:C0085297

object_name: Neuroinflammation


subject: UMLS:C0085297

object_name: Microvascular Thrombosis Related to COVID-19


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:63791

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:63791

object_name: testicular lymphoma


subject: CHEBI:63791

object_name: intraocular lymphoma


subject: CHEBI:63791

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:63791

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:63791

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:63791

object_name: anaplastic large cell lymphoma


subject: CHEBI:63791

object_name: small intestine lymphoma


subject: CHEBI:63791

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:63791

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:63791

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:63791

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:63791

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:63791

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:63791

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:63791

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:63791

object_name: splenic marginal zone lymphoma


subject: CHEBI:63791

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:63791

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:63791

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:63791

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:63791

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:63791

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:63791

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:63791


subject: CHEBI:63791

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:45716

subject_name: Vorinostat

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:45716

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: UMLS:C5962170

subject_name: Androgen Receptor Pathway Inhibitor

object_name: prostate carcinoma


subject: UMLS:C5962170

object_name: prostate cancer


subject: UMLS:C5962170

object_name: Hormone sensitive prostate cancer


subject: UMLS:C5962170

object_name: prostate adenocarcinoma


subject: UMLS:C4278474

object_name: inflammatory bowel disease 1


subject: UMLS:C4278474

object_name: Crohn disease


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: glioblastoma


subject: GTOPDB:9758

object_name: Childhood Glioblastoma


subject: GTOPDB:9758

object_name: adult glioblastoma


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: CHEBI:7465

subject_name: Naltrexone

object_name: pain agnosia


subject: CHEBI:7465

object_name: Pain insensitivity


subject: CHEBI:16822

subject_name: choline sulfate

object_name: prenatal stress


subject: CHEBI:15354

subject_name: Choline


subject: CHEBI:173763

subject_name: Thermophillin

object_name: alcohol-related disorders


subject: PUBCHEM.COMPOUND:23597337

subject_name: Physalin L


subject: CHEBI:4659

subject_name: Disulfiram


subject: UMLS:C4721874

subject_name: human insulin

object_name: type 2 diabetes mellitus


subject: CHEBI:6770

subject_name: MEROPENEM

object_name: Febrile Neutropenia


subject: CHEBI:6770

object_name: Febrile Neutropenia, CTCAE


subject: CHEBI:6770

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: CHEBI:43968

subject_name: Meropenem


subject: CHEBI:43968


subject: CHEBI:43968


subject: UMLS:C5190278

subject_name: SMOF lipid

object_name: nervous system complication


subject: UNII:C9H2L21V7U

subject_name: SMOFlipid


subject: CHEBI:7466

subject_name: Nandrolone

object_name: Control of hip fracture risk


subject: CHEBI:7466

object_name: hip fracture


subject: UNII:8H61Y4E29N

subject_name: Ortataxel

object_name: lung cancer


subject: UNII:8H61Y4E29N

object_name: lung neoplasm


subject: UNII:8H61Y4E29N

object_name: lung carcinoma


subject: UMLS:C5854552

subject_name: Anti-B7H7 Monoclonal Antibody HBM1020

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:60799

subject_name: Esketamine

object_name: Postoperative delirium


subject: CHEBI:60799

object_name: Emergence Delirium


subject: CHEBI:177824

subject_name: Terameprocol

object_name: adult lymphoma


subject: CHEBI:177824

object_name: lymphoma


subject: CHEBI:177824

object_name: pediatric lymphoma


subject: UMLS:C1831769


subject: UMLS:C1831769


subject: UMLS:C1831769


subject: PR:000001345

subject_name: endoglin

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: PR:000001345

object_name: Carcinoma breast stage IV


subject: PR:000001345

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: PR:000001345

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: PR:000001345

object_name: Stage III Breast Cancer AJCC v7


subject: PR:000001345

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: PR:000001345

object_name: Breast cancer stage III


subject: PR:000001345

object_name: Stage III Breast Cancer AJCC v6


subject: PR:000001345

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: PR:000001345

object_name: Stage IIIB Breast Carcinoma


subject: PR:000001345

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: PR:000001345

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: PR:000001345

object_name: Stage IIIC Breast Cancer AJCC v6


subject: PR:000001345

object_name: Stage IIIC Breast Cancer AJCC v7


subject: PR:000001345

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: PR:000001345

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: PR:000001345

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: PR:000001345

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: PR:000001345

object_name: Stage IIIA Breast Carcinoma


subject: PR:000001345

object_name: Her2-receptor negative breast cancer


subject: PR:000001345

object_name: Breast cancer recurrent


subject: PR:000017525

subject_name: Y-box-binding protein 1

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: PR:000017525

object_name: Carcinoma breast stage IV


subject: PR:000017525

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: PR:000017525

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: PR:000017525

object_name: Stage III Breast Cancer AJCC v7


subject: PR:000017525

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: PR:000017525

object_name: Breast cancer stage III


subject: PR:000017525

object_name: Stage III Breast Cancer AJCC v6


subject: PR:000017525

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: PR:000017525

object_name: Stage IIIB Breast Carcinoma


subject: PR:000017525

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: PR:000017525

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: PR:000017525

object_name: Stage IIIC Breast Cancer AJCC v6


subject: PR:000017525

object_name: Stage IIIC Breast Cancer AJCC v7


subject: PR:000017525

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: PR:000017525

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: PR:000017525

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: PR:000017525

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: PR:000017525

object_name: Stage IIIA Breast Carcinoma


subject: PR:000017525

object_name: Her2-receptor negative breast cancer


subject: PR:000017525

object_name: Breast cancer recurrent


subject: CHEBI:35457

subject_name: EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor

object_name: myocardial infarction


subject: CHEBI:35457

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:35457

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:35457

object_name: coronary artery disorder


subject: CHEBI:35457

object_name: cardiovascular disorder


subject: CHEBI:35457

object_name: myocardial ischemia


subject: CHEBI:35457

object_name: coronary atherosclerosis


subject: CHEBI:35457

object_name: heart disorder


subject: UMLS:C0003015


subject: UMLS:C0003015


subject: UMLS:C0003015


subject: UMLS:C0003015


subject: UMLS:C0003015


subject: UMLS:C0003015


subject: UMLS:C0003015


subject: UMLS:C0003015


subject: UMLS:C1883272

subject_name: Folate Receptor-Targeted Technetium Tc-99m EC20

object_name: multiple sclerosis


subject: UMLS:C1883272

object_name: osteoarthritis


subject: UMLS:C1883272

object_name: rheumatoid arthritis


subject: UMLS:C1883272

object_name: Crohn disease


subject: UMLS:C1883272

object_name: EXCESS LMW-DNA


subject: UMLS:C2984025

subject_name: Ferinject

object_name: anemia


subject: UMLS:C2984025

object_name: Anemia, CTCAE


subject: UMLS:C2984025

object_name: pancreatic neoplasm


subject: UMLS:C2984025

object_name: exocrine pancreatic carcinoma


subject: UMLS:C2984025

object_name: malignant pancreatic neoplasm


subject: UNII:6897GXD6OE


subject: UNII:6897GXD6OE


subject: UNII:6897GXD6OE


subject: HMDB:HMDB0014869

subject_name: Nateglinide

object_name: Posttransplant diabetes mellitus


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: osteoarthritis, knee


subject: CHEBI:85106

subject_name: N-acetyl-alpha-L-talosaminuronic acid

object_name: Malignant neoplasm of pancreas resectable


subject: CHEBI:85106

object_name: Stage II Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:74640

subject_name: N-acetyl-L-tryptophan


subject: CHEBI:74640


subject: CHEBI:82508

subject_name: N'-Nitrosoanatabine


subject: CHEBI:82508


subject: CHEBI:84415

subject_name: acetyltaurine


subject: CHEBI:84415


subject: PR:000015120

subject_name: sodium-coupled neutral amino acid transporter 3


subject: PR:000015120


subject: PR:000002097

subject_name: sodium channel protein type 11 subunit alpha


subject: PR:000002097


subject: UMLS:C0124604

subject_name: Catha edulis (substance)


subject: UMLS:C0124604


subject: CHEBI:24433

subject_name: group


subject: CHEBI:24433


subject: PUBCHEM.COMPOUND:23667621

subject_name: DEXAMETHASONE SODIUM PHOSPHATE

object_name: Juvenile apophysitis


subject: CHEBI:41879

subject_name: Dexamethasone


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: digestive system cancer


subject: UMLS:C4547969

subject_name: apatinib mesylate


subject: GTOPDB:9758

subject_name: camrelizumab


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: CHEBI:31687

subject_name: Idebenone

object_name: REM sleep behavior disorder


subject: CHEBI:31687

object_name: synucleinopathy


subject: CHEBI:8214

subject_name: Pindolol

object_name: Cachexia


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: Primary nocturnal enuresis


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: adult germ cell tumor


subject: CHEBI:175901

object_name: germ cell tumor


subject: CHEBI:175901

object_name: childhood germ cell tumor


subject: CHEBI:175901

object_name: Germ Cell Cancer


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: GTOPDB:4934

subject_name: G-CSF


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:94843

subject_name: Vicriviroc

object_name: HIV infection


subject: CHEBI:17026

subject_name: Progesterone

object_name: Cannabis withdrawal


subject: CHEBI:17026

object_name: Cannabis use disorder


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UMLS:C2757070


subject: CHEBI:34906

subject_name: Patent blue

object_name: Childhood Breast Carcinoma


subject: CHEBI:34906

object_name: breast carcinoma


subject: CHEBI:34906

object_name: breast cancer


subject: UMLS:C3152625

subject_name: Pneumococcal 13-valent conjugate vaccine

object_name: infectious disease


subject: UMLS:C1579314

subject_name: Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed


subject: UMLS:C3526553

subject_name: diphtheria, tetanus toxoids and acellular pertussis vaccine


subject: MESH:D011054

subject_name: Poliovirus Vaccine, Inactivated


subject: MESH:C044237

subject_name: Haemophilus influenzae type b polysaccharide vaccine


subject: MESH:D008458

subject_name: Measles Vaccine


subject: MESH:D009108

subject_name: Mumps Vaccine


subject: UMLS:C0035923

subject_name: Rubella Vaccine


subject: UMLS:C5397335

subject_name: Vaccine product containing only Rubella virus antigen (medicinal product)


subject: UMLS:C0065828

subject_name: Measles-Mumps-Rubella Vaccine


subject: CHEBI:44177

subject_name: Isocyanomethane


subject: CHEBI:143712

subject_name: N. meningitidis group C polysaccharide


subject: UMLS:C0597418

subject_name: Rotavirus Vaccines


subject: UMLS:C5397359

subject_name: Vaccine product containing only Rotavirus antigen (medicinal product)


subject: MESH:C484361

subject_name: karinat

object_name: arteriosclerosis disorder


subject: MESH:C484361

object_name: atherosclerosis


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Failed or difficult intubation


subject: CHEBI:4466

object_name: Sedative adverse reaction


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam


subject: PUBCHEM.COMPOUND:9824461


subject: UMLS:C5444737

subject_name: Flaxseed antigen

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C5444737

object_name: metabolic syndrome X


subject: DRUGBANK:DB10708

subject_name: Flax seed


subject: DRUGBANK:DB10708


subject: CHEBI:15365

subject_name: Aspirin

object_name: abortion


subject: CHEBI:15365

object_name: Pregnancy loss


subject: CHEBI:15365

object_name: Pregnancy Loss, CTCAE


subject: CHEBI:15365

object_name: Antiphospholipid syndrome in pregnancy


subject: CHEBI:34906

subject_name: Patent blue

object_name: endometrial carcinoma


subject: CHEBI:43602

subject_name: Obeticholic acid

object_name: sclerosing cholangitis


subject: UMLS:C5779650


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: carcinoma


subject: UMLS:C5706408

subject_name: Anti-c-Met Antibody-drug Conjugate BYON3521

object_name: Childhood Solid Neoplasm


subject: UMLS:C5706408

object_name: Adult Solid Neoplasm


subject: UMLS:C5706408

object_name: Solid Neoplasm


subject: CHEBI:73657

subject_name: Thr-Ala-Ser

object_name: prostate carcinoma


subject: CHEBI:73657

object_name: prostate cancer


subject: CHEBI:30049

subject_name: teichoic acid


subject: CHEBI:30049


subject: PR:000024027

subject_name: protein tas


subject: PR:000024027


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Colon Neoplasm


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1522140


subject: GTOPDB:8415

subject_name: tanezumab

object_name: osteoarthritis, knee


subject: GTOPDB:8415

object_name: osteoarthritis, hip


subject: UNII:EQL0E9GCX1


subject: UNII:EQL0E9GCX1


subject: UMLS:C2346819


subject: UMLS:C2346819


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:71226663

object_name: chronic leukemia


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: Suicidal ideation


subject: PUBCHEM.COMPOUND:9848990

object_name: Suicidal Ideation, CTCAE


subject: CHEBI:73611

subject_name: Met-Gly


subject: CHEBI:73611


subject: CHEBI:73611

object_name: opiate dependence


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:25107


subject: PR:000004501

subject_name: attractin


subject: PR:000004501


subject: PR:000004501


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UMLS:C0487173


subject: UMLS:C0487173


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: type 2 diabetes mellitus


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:60802

subject_name: ropivacaine

object_name: breast neoplasm


subject: UMLS:C1550146

subject_name: Other - Substance Type

object_name: non-small cell lung carcinoma


subject: UMLS:C4528719

object_name: endometrial carcinoma


subject: UMLS:C4528719

object_name: suppressor of tumorigenicity 3


subject: UMLS:C4528719

object_name: cervical carcinoma


subject: UMLS:C4528719

object_name: primary peritoneal carcinoma


subject: UMLS:C4528719

object_name: papillary serous cystadenocarcinoma


subject: UMLS:C4528719

object_name: peritoneal carcinoma


subject: UMLS:C4528719

object_name: ovarian cancer


subject: UMLS:C4528719

object_name: ovarian carcinoma


subject: UMLS:C4528719

object_name: malignant epithelial tumor of ovary


subject: UMLS:C4528719

object_name: fallopian tube carcinoma


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:137262

subject_name: Leu-Asn-Ser

object_name: hereditary endocrine growth disease


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Epiphora


subject: PUBCHEM.COMPOUND:72455102

subject_name: Vorapaxar

object_name: HIV infection


subject: CHEBI:36704

subject_name: Imiquimod

object_name: High Grade Intraepithelial Neoplasia


subject: CHEBI:63631

subject_name: Topiramate

object_name: nicotine dependence


subject: UNII:4Y05SI704S

subject_name: SOMAVARATAN

object_name: Adult growth hormone deficiency


subject: UMLS:C4519725

subject_name: Somavaratan


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Hair-pulling


subject: UMLS:C4053688

subject_name: ADC ABBV-838

object_name: plasma cell myeloma


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: osteoarthritis, hip


subject: CHEBI:3215

object_name: osteoarthritis susceptibility 5


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: adverse effect to anesthesia


subject: CHEBI:137359

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:137359

object_name: obesity


subject: CHEBI:137359

object_name: Obesity, CTCAE


subject: CHEBI:37084

subject_name: beta-Hydroxyisovaleric acid


subject: CHEBI:37084


subject: CHEBI:37084


subject: CHEMBL.COMPOUND:CHEMBL4525124

subject_name: HMB


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Failed induction (of labor) by oxytocin


subject: PUBCHEM.COMPOUND:53477758

object_name: Failed attempted vaginal birth after previous cesarean section


subject: PUBCHEM.COMPOUND:53477758

object_name: Unspecified failed trial of labor, delivered, with or without mention of antepartum condition


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: Crohn disease


subject: CHEBI:3311

object_name: vitamin D deficiency


subject: MESH:D056692

subject_name: Prebiotics

object_name: Prematurity of fetus


subject: MESH:D056692

object_name: Premature infant


subject: MESH:D056692

object_name: Nutritional status


subject: UNII:ISL723GVQ8


subject: UNII:ISL723GVQ8


subject: UNII:ISL723GVQ8


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: Dyssomnias


subject: UNII:420K487FSG

object_name: Sleep abnormality


subject: UNII:420K487FSG

object_name: sleep disorder


subject: UMLS:C3658854


subject: UMLS:C3658854


subject: UMLS:C3658854


subject: UMLS:C2729274

subject_name: Injection, onabotulinumtoxina, 1 unit

object_name: Compartment syndrome of lower limb due to traumatic injury


subject: CHEBI:3423

subject_name: Carmustine

object_name: Childhood Diffuse Large Cell Lymphoma


subject: CHEBI:3423

object_name: Adult Diffuse Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: MESH:C421461

subject_name: glubran 2

object_name: pancreatic neoplasm


subject: MESH:C421461

object_name: exocrine pancreatic carcinoma


subject: MESH:C421461

object_name: malignant pancreatic neoplasm


subject: MESH:C421461

object_name: Duodenal Cancer


subject: MESH:C421461

object_name: carcinoma of duodenum


subject: MESH:C421461

object_name: duodenum cancer


subject: MESH:C421461

object_name: pancreatic ductal adenocarcinoma


subject: MESH:C421461

object_name: periampullary adenocarcinoma


subject: MESH:C421461

object_name: cholangiocarcinoma


subject: MESH:C421461

object_name: bile duct carcinoma


subject: MESH:C421461

object_name: bile duct cancer


subject: PUBCHEM.COMPOUND:2307

subject_name: Andion

object_name: chronic obstructive pulmonary disease


subject: CHEBI:3001

subject_name: beclomethasone


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Low back pain


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: UNII:ZH5SMU97AJ

object_name: lung disorder


subject: UNII:ZH5SMU97AJ

object_name: obstructive lung disease


subject: CHEBI:50381

subject_name: Miglustat

object_name: cystic fibrosis


subject: PUBCHEM.COMPOUND:71300725

subject_name: Etirinotecan pegol

object_name: anaplastic astrocytoma


subject: PUBCHEM.COMPOUND:71300725

object_name: anaplastic oligodendroglioma


subject: UNII:LJ16641SFT


subject: UNII:LJ16641SFT


subject: UNII:BI009E452R

subject_name: Andexanet alfa

object_name: Surgical procedure finding


subject: UMLS:C4045506


subject: UMLS:C1541521

subject_name: AMG 386

object_name: cancer


subject: UMLS:C1541521

object_name: neoplasm


subject: UMLS:C1541521

object_name: metastatic colorectal cancer


subject: UMLS:C1541521

object_name: carcinoma


subject: UMLS:C1541521

object_name: colorectal cancer


subject: UMLS:C1541521

object_name: colorectal carcinoma


subject: UMLS:C1541521

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1541521

object_name: rectal carcinoma


subject: UMLS:C1541521

object_name: rectal cancer


subject: UMLS:C1541521

object_name: Childhood Rectal Carcinoma


subject: UMLS:C1541521

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C1541521

object_name: Embolism, Tumor


subject: UMLS:C1541521

object_name: Neoplasm Metastasis


subject: UMLS:C1541521

object_name: Metastatic Lesion


subject: UMLS:C1541521

object_name: colon carcinoma


subject: UMLS:C1541521

object_name: colon cancer


subject: UMLS:C1541521

object_name: digestive system cancer


subject: CHEBI:73629

subject_name: Phe-Asp-Cys

object_name: myocardial infarction


subject: CHEBI:73629

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:73629

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:38848

subject_name: perflunafene


subject: CHEBI:38848


subject: CHEBI:38848


subject: PR:000001881

subject_name: lymphocyte activation gene 3 protein


subject: PR:000001881


subject: PR:000001881


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Locally Advanced Malignant Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297925

subject_name: EXEBACASE


subject: CHEMBL.COMPOUND:CHEMBL4297925

object_name: Bacteremia caused by Methicillin resistant Staphylococcus aureus


subject: UMLS:C5238170

subject_name: exebacase


subject: UMLS:C5238170


subject: UNII:DLG4EML025

subject_name: Secukinumab

object_name: psoriasis-related juvenile idiopathic arthritis


subject: UNII:DLG4EML025

object_name: enthesitis-related juvenile idiopathic arthritis


subject: RXCUI:1999664

subject_name: bictegravir / emtricitabine / tenofovir alafenamide Oral Product

object_name: HCV coinfection


subject: RXCUI:1999664

object_name: coinfection


subject: RXCUI:1999664

object_name: Buprenorphine dependence


subject: RXCUI:1999664

object_name: Methadone dependence


subject: RXCUI:1999664

object_name: opiate dependence


subject: RXCUI:1999664

object_name: metabolic bone disorder


subject: RXCUI:1999664

object_name: chronic hepatitis C virus infection


subject: RXCUI:1999664

object_name: AIDS


subject: CHEBI:133008

subject_name: Epclusa


subject: CHEBI:133008


subject: CHEBI:133008


subject: CHEBI:133008


subject: CHEBI:133008

object_name: HIV-1 infection


subject: CHEBI:133008


subject: CHEBI:133008


subject: CHEBI:133008


subject: CHEBI:133008


subject: RXCUI:1799208

subject_name: sofosbuvir / velpatasvir Oral Product


subject: RXCUI:1799208


subject: RXCUI:1799208


subject: RXCUI:1799208


subject: RXCUI:1799208


subject: RXCUI:1799208


subject: RXCUI:1799208


subject: RXCUI:1799208


subject: RXCUI:1799208


subject: CHEBI:90922

subject_name: Genvoya


subject: CHEBI:90922


subject: CHEBI:90922


subject: CHEBI:90922


subject: CHEBI:90922


subject: CHEBI:90922


subject: CHEBI:90922


subject: CHEBI:90922


subject: CHEBI:90922


subject: CHEBI:90926

subject_name: Tenofovir alafenamide


subject: CHEBI:90926


subject: CHEBI:90926


subject: CHEBI:90926


subject: CHEBI:90926


subject: CHEBI:90926


subject: CHEBI:90926


subject: CHEBI:90881

subject_name: Camptosar

object_name: Stomach cancer


subject: CHEBI:90881

object_name: gastric cancer


subject: CHEBI:90881


subject: DRUGBANK:DB10640

subject_name: Beet

object_name: chronic kidney disease


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: bipolar I disorder


subject: UNII:GQZ99GWR3T

object_name: mucositis


subject: DRUGBANK:DB18822


subject: CHEBI:5613

subject_name: Haloperidol

object_name: delirium


subject: CHEBI:5613

object_name: Delirium, CTCAE


subject: CHEBI:5613

object_name: cognitive disorder


subject: CHEBI:10119

subject_name: Ziprasidone


subject: CHEBI:10119


subject: CHEBI:10119


subject: CHEBI:31401

subject_name: Cilostazol

object_name: peripheral vascular disease


subject: CHEBI:31401

object_name: peripheral arterial disease


subject: CHEBI:31401

object_name: Ischemic stroke


subject: CHEBI:37941

subject_name: Clopidogrel


subject: CHEBI:37941


subject: CHEBI:37941

object_name: type 2 diabetes mellitus


subject: CHEBI:47381

subject_name: Diclofenac


subject: PUBCHEM.COMPOUND:152165


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV

object_name: Locally Advanced Intrahepatic Cholangiocarcinoma


subject: UNII:28X28X9OKV

object_name: Stage III Intrahepatic Cholangiocarcinoma AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IV Intrahepatic Cholangiocarcinoma AJCC v8


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: PUBCHEM.COMPOUND:71271414

object_name: Acute schizophrenic episode


subject: UNII:7M430JI73B


subject: UMLS:C4688403

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C4688403

object_name: B-cell neoplasm


subject: CHEBI:7852

subject_name: Oxycodone

object_name: Labor Pain


subject: CHEBI:36796

subject_name: duloxetine

object_name: binge eating


subject: CHEBI:36796

object_name: Binge eating behavior


subject: PUBCHEM.COMPOUND:9800288

subject_name: METOPROLOL SUCCINATE

object_name: Female sexual dysfunction


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:64019

subject_name: Nebivolol


subject: UNII:KQA6N2NT4Z

subject_name: RULONILIMAB

object_name: cervical cancer


subject: UNII:KQA6N2NT4Z

object_name: cervical carcinoma


subject: UMLS:C5206710


subject: UMLS:C5206710


subject: CHEBI:6456

subject_name: Lidocaine

object_name: pain agnosia


subject: CHEBI:6456

object_name: Pain insensitivity


subject: CHEBI:6456

object_name: Epistaxis, CTCAE


subject: CHEBI:6456

object_name: Epistaxis


subject: UNII:06IVK87M04

subject_name: Zelavespib

object_name: myelofibrosis


subject: UNII:06IVK87M04

object_name: Post-polycythemia vera myelofibrosis


subject: UNII:06IVK87M04


subject: UMLS:C4310558


subject: UMLS:C4310558


subject: UMLS:C4310558


subject: CHEBI:57694


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:6931

subject_name: Midazolam

object_name: alcohol abuse


subject: CHEBI:6931

object_name: alcohol dependence


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: DRUGBANK:DB16693

subject_name: Insulin icodec

object_name: type 1 diabetes mellitus 1


subject: DRUGBANK:DB16693

object_name: type 1 diabetes mellitus


subject: UMLS:C5556557

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5556557

object_name: acute myeloid leukemia


subject: UMLS:C5556557

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5556557

object_name: plasma cell myeloma


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:5959

subject_name: Irbesartan

object_name: atrial fibrillation


subject: CHEBI:5959

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:5959

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: osteoarthritis


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Fasting


subject: CHEBI:3215

object_name: Intraoperative Complication


subject: CHEBI:3215

object_name: ischemia


subject: UMLS:C4547221

object_name: EXCESS LMW-DNA


subject: CHEBI:81916

subject_name: Pancrelipase

object_name: exocrine pancreatic insufficiency


subject: UNII:FQ3DRG0N5K


subject: UMLS:C0111046

subject_name: Creon


subject: UMLS:C1302030

subject_name: amylase / lipase / protease


subject: CHEBI:7457

subject_name: Nalmefene

object_name: Gambling


subject: CHEBI:8884

subject_name: Rocuronium

object_name: Post-Operative Pain


subject: UMLS:C1135124

object_name: melanoma


subject: UMLS:C1135124

object_name: metastatic melanoma


subject: CHEBI:5050

subject_name: Fexofenadine

object_name: Atopic rhinitis


subject: CHEBI:5050

object_name: Allergic Rhinitis, CTCAE


subject: PUBCHEM.COMPOUND:86305217

subject_name: DALZANEMDOR

object_name: Huntington disease


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: Acute Ischemic Stroke


subject: UNII:6GNT3Y5LMF

object_name: Ischemic stroke


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63598


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: cesarean section; dehiscence


subject: UMLS:C1710381

subject_name: Circadin

object_name: Alzheimer disease


subject: UMLS:C1710381

object_name: sleep disorder


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: Peptic Ulcer Hemorrhage


subject: UMLS:C1618891

subject_name: Injection, azacitidine, 1 mg administered

object_name: acute myeloid leukemia


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: POEMS syndrome


subject: CHEBI:41879

subject_name: Dexamethasone


subject: UMLS:C2826139


subject: CHEBI:2682

subject_name: Amphotericin B

object_name: Febrile Neutropenia


subject: CHEBI:2682

object_name: Febrile Neutropenia, CTCAE


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:135515

subject_name: Bendamustine

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Surgical procedure finding


subject: CHEBI:42797

object_name: bariatric surgery candidate


subject: UMLS:C0724033

subject_name: Tylenol Suspension


subject: UMLS:C0724033


subject: UMLS:C0724033

object_name: obesity due to congenital leptin deficiency


subject: UMLS:C0724033

object_name: obesity due to leptin receptor gene deficiency


subject: UMLS:C0724033

object_name: morbid obesity


subject: CHEBI:6121

subject_name: Ketamine

object_name: borderline personality disorder


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: rectal carcinoma


subject: PUBCHEM.COMPOUND:92043599

object_name: rectal cancer


subject: PUBCHEM.COMPOUND:92043599

object_name: Childhood Rectal Carcinoma


subject: PUBCHEM.COMPOUND:92043599

object_name: digestive system cancer


subject: CHEBI:137359

object_name: prostate carcinoma


subject: CHEBI:137359

object_name: prostate cancer


subject: CHEBI:37084

subject_name: beta-Hydroxyisovaleric acid


subject: CHEBI:37084


subject: CHEMBL.COMPOUND:CHEMBL4525124

subject_name: HMB


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEBI:32696


subject: CHEBI:32696


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: CHEBI:17061

subject_name: D-Glutamine


subject: CHEBI:17061


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:28300


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: CHEBI:7009

subject_name: Moxonidine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:7009

object_name: obesity


subject: CHEBI:7009

object_name: Obesity, CTCAE


subject: CHEBI:59729

subject_name: fenfluramine hydrochloride

object_name: Dravet syndrome


subject: CHEBI:59729

object_name: developmental and epileptic encephalopathy, 6A


subject: CHEBI:5000

subject_name: Fenfluramine


subject: CHEBI:5000


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: laryngeal carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: larynx cancer


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:44915

subject_name: Propofol

object_name: Postoperative Residual Curarization


subject: CHEBI:16664

subject_name: Albendazole

object_name: HIV infection


subject: CHEBI:16664

object_name: helminthiasis


subject: CHEBI:45267

subject_name: praziquantel


subject: CHEBI:45267


subject: CHEBI:91583

subject_name: Praziquantel


subject: CHEBI:91583


subject: UNII:PYZ33YLR8A

object_name: Acute Stroke


subject: UNII:C9R35M8XV6

subject_name: Hiberix

object_name: poliomyelitis


subject: UNII:C9R35M8XV6

object_name: hepatitis B


subject: UNII:C9R35M8XV6

object_name: diphtheria


subject: UNII:C9R35M8XV6

object_name: tetanus


subject: UNII:NU90V55F8I

subject_name: Sarilumab

object_name: Plaque morphea


subject: GTOPDB:12990

subject_name: sintilimab

object_name: malignant peritoneal mesothelioma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: UMLS:C0114857

subject_name: Dotarem

object_name: brain disorder


subject: UMLS:C2703133

object_name: myelofibrosis


subject: UMLS:C2703133

object_name: myeloproliferative neoplasm


subject: UMLS:C2703133

object_name: essential thrombocythemia


subject: UMLS:C2703133

object_name: acquired polycythemia vera


subject: CHEBI:231350

subject_name: Pacritinib


subject: CHEBI:231350


subject: CHEBI:231350


subject: CHEBI:136041

subject_name: Tofogliflozin


subject: UMLS:C3501433


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: uveal melanoma


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: nasopharyngeal carcinoma


subject: UNII:GKF8S4C432

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UNII:PF8K38CG54

subject_name: Fremanezumab

object_name: Episodic Cluster Headache


subject: UNII:PF8K38CG54

object_name: cluster headache syndrome


subject: UMLS:C1250042

subject_name: oxytocin nasal spray

object_name: Depressive Symptoms


subject: PR:000034030

subject_name: FMN reductase (NADH) RutF

object_name: Child Nutrition Disorders


subject: UNII:2S9ZZM9Q9V

object_name: Colon cancer recurrent


subject: UNII:2S9ZZM9Q9V

object_name: colon mucinous adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: colon signet ring cell adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: rectum adenocarcinoma


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UNII:PQX0D8J21J


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: CHEBI:3175

subject_name: Brimonidine

object_name: OPTN-related open angle glaucoma


subject: CHEBI:3175

object_name: open-angle glaucoma


subject: UNII:LZZ0IC2EWP

subject_name: SASANLIMAB

object_name: Neck Carcinoma


subject: UNII:LZZ0IC2EWP

object_name: head and neck neoplasm


subject: UNII:LZZ0IC2EWP

object_name: head and neck cancer


subject: UNII:LZZ0IC2EWP

object_name: melanoma


subject: UNII:LZZ0IC2EWP

object_name: bladder tumor


subject: UNII:LZZ0IC2EWP

object_name: urinary bladder carcinoma


subject: UNII:LZZ0IC2EWP

object_name: urinary bladder cancer


subject: UNII:LZZ0IC2EWP

object_name: childhood bladder carcinoma


subject: UNII:LZZ0IC2EWP

object_name: colorectal cancer


subject: UNII:LZZ0IC2EWP

object_name: colorectal carcinoma


subject: UNII:LZZ0IC2EWP

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:LZZ0IC2EWP

object_name: nonpapillary renal cell carcinoma


subject: UNII:LZZ0IC2EWP

object_name: clear cell renal carcinoma


subject: UNII:LZZ0IC2EWP

object_name: renal cell adenocarcinoma


subject: UNII:LZZ0IC2EWP

object_name: renal cell carcinoma


subject: PUBCHEM.COMPOUND:71301229

subject_name: Xelox

object_name: persistent idiopathic facial pain


subject: UNII:1B8447E7YI

subject_name: CLOMIPHENE CITRATE

object_name: paroxysmal familial ventricular fibrillation


subject: UNII:1B8447E7YI

object_name: ventricular fibrillation, paroxysmal familial, type 1


subject: CHEBI:3752

subject_name: Clomifene


subject: CHEBI:3752


subject: GTOPDB:4391

subject_name: LH


subject: GTOPDB:4391


subject: CHEBI:74539

subject_name: Leu-His


subject: CHEBI:74539


subject: CHEBI:81568

subject_name: luteinizing hormone


subject: CHEBI:81568


subject: CHEBI:59224

subject_name: Cetrorelix


subject: CHEBI:59224


subject: CHEBI:63633

subject_name: Triptorelin


subject: CHEBI:63633


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Whiplash Injuries


subject: CHEBI:9150

subject_name: Simvastatin

object_name: pancreatic neoplasm


subject: CHEBI:9150

object_name: exocrine pancreatic carcinoma


subject: CHEBI:9150

object_name: malignant pancreatic neoplasm


subject: CHEBI:87631

subject_name: statin

object_name: HMG COA reductase inhibitor adverse reaction


subject: CHEBI:9150


subject: UMLS:C1456454

subject_name: Amyloid Proteins

object_name: Alzheimer disease type 1


subject: UMLS:C1456454

object_name: Alzheimer disease


subject: UMLS:C0002716

subject_name: Amyloid


subject: UMLS:C0002716


subject: CHEBI:135323

subject_name: Gestodene

object_name: Uses contraception (finding)


subject: GTOPDB:13535

subject_name: drisapersen

object_name: muscular dystrophy


subject: CHEMBL.COMPOUND:CHEMBL2108735

subject_name: DRISAPERSEN


subject: CHEBI:95021

subject_name: pemetrexed

object_name: primary central nervous system lymphoma


subject: CHEBI:63724


subject: CHEBI:31355

subject_name: Carboplatin

object_name: BRCA1 gene mutation


subject: CHEBI:31355

object_name: BRCA Gene Mutation


subject: CHEBI:31355

object_name: BRCA2 gene mutation


subject: CHEBI:31355

object_name: BRCA Hereditary Breast Carcinoma


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P

object_name: breast neoplasm


subject: CHEBI:15372

object_name: Pancreatic adenocarcinoma metastatic


subject: PUBCHEM.COMPOUND:129630809

subject_name: trihydroxybutyrophenone


subject: CHEBI:173969


subject: CHEBI:59560

subject_name: Sapropterin


subject: CHEBI:7852

subject_name: Oxycodone

object_name: cancer


subject: CHEBI:7852

object_name: neoplasm


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: Dysglycemia


subject: UMLS:C3714501


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: UMLS:C0106006

object_name: heart failure


subject: UMLS:C0062248

subject_name: Hemoglobin B


subject: CHEBI:35701

subject_name: ester


subject: CHEBI:151315

subject_name: Heparin

object_name: Hemorrhage


subject: CHEBI:151315

object_name: Surgical procedure finding


subject: CHEBI:151315

object_name: liver cancer


subject: CHEBI:151315

object_name: liver neoplasm


subject: CHEBI:151315

object_name: Adult Liver Carcinoma


subject: CHEBI:151315

object_name: liver carcinoma


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:E47C0NF7LV


subject: UNII:E47C0NF7LV


subject: UNII:E47C0NF7LV


subject: UNII:E47C0NF7LV


subject: UNII:E47C0NF7LV


subject: UNII:E47C0NF7LV

object_name: Deep venous thrombosis


subject: UNII:E47C0NF7LV

object_name: pulmonary embolism


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: UNII:7UQ7X4Y489

subject_name: TINZAPARIN


subject: UNII:7UQ7X4Y489


subject: UNII:7UQ7X4Y489


subject: UNII:7UQ7X4Y489


subject: UNII:7UQ7X4Y489


subject: UNII:7UQ7X4Y489


subject: UNII:7UQ7X4Y489


subject: UNII:7UQ7X4Y489


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: GTOPDB:6803

subject_name: dalteparin


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: UNII:5QS67N4551

subject_name: Conestat alfa

object_name: hereditary angioedema


subject: UNII:5QS67N4551

object_name: genetic disease


subject: GTOPDB:9125

object_name: colorectal cancer


subject: GTOPDB:9125

object_name: colorectal carcinoma


subject: GTOPDB:9125

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3275035


subject: UMLS:C3275035


subject: UMLS:C3275035


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:24956525

subject_name: Tyrosine kinase inhibitor

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: PUBCHEM.COMPOUND:24956525


subject: UMLS:C1268567

subject_name: Protein-tyrosine kinase inhibitor


subject: UMLS:C1268567


subject: UMLS:C1655276

subject_name: T-KI


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: social interaction (history)


subject: UMLS:C0592155

subject_name: Syntocinon


subject: PUBCHEM.COMPOUND:126756

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: PUBCHEM.COMPOUND:126756

object_name: amyotrophic lateral sclerosis


subject: CHEBI:34992

subject_name: Talampanel


subject: CHEBI:34992


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: central nervous system infectious disorder


subject: UNII:R8DG7T2D3A

object_name: Central Nervous System Vascular Malformations


subject: UNII:R8DG7T2D3A

object_name: neurodegenerative disease


subject: UNII:R8DG7T2D3A

object_name: brain injury


subject: UNII:R8DG7T2D3A

object_name: primary brain neoplasm


subject: UNII:R8DG7T2D3A

object_name: intracerebral hemorrhage


subject: UNII:R8DG7T2D3A

object_name: Ischemic stroke


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: UNII:CLH5FT6412


subject: UNII:CLH5FT6412


subject: UNII:CLH5FT6412


subject: UNII:CLH5FT6412


subject: UNII:CLH5FT6412


subject: UNII:CLH5FT6412


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:46726


subject: CHEBI:46726


subject: CHEBI:46726


subject: CHEBI:46726


subject: CHEBI:46726


subject: CHEBI:46726


subject: CHEBI:187893

subject_name: Baclofen

object_name: Spasticity


subject: CHEBI:187893

object_name: spinal cord injury


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: pancreatic neoplasm


subject: CHEBI:3215

object_name: malignant pancreatic neoplasm


subject: CHEBI:3215

object_name: duodenum cancer


subject: CHEBI:3215

object_name: tumor of duodenum


subject: CHEBI:5790

subject_name: Hydromorphone


subject: CHEBI:5790


subject: CHEBI:5790


subject: CHEBI:5790


subject: PUBCHEM.COMPOUND:3734

subject_name: Iopamidol


subject: PUBCHEM.COMPOUND:3734


subject: PUBCHEM.COMPOUND:3734


subject: PUBCHEM.COMPOUND:3734


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine


subject: UMLS:C4086546


subject: UMLS:C4086546


subject: UMLS:C4086546


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: digestive system neoplasm


subject: CHEBI:175901

object_name: Neoplasm of the gastrointestinal tract


subject: UNII:997WVV895X

subject_name: Rimegepant

object_name: Transformed migraine


subject: UNII:997WVV895X

object_name: migraine with aura


subject: UNII:997WVV895X

object_name: Common Migraine


subject: CHEBI:136037

subject_name: Corticorelin

object_name: Cushing syndrome


subject: CHEBI:136037

object_name: hyperaldosteronism


subject: CHEBI:136037

object_name: Addison Disease


subject: CHEBI:136037

object_name: adrenocortical insufficiency


subject: CHEBI:136037

object_name: adrenal gland hyperfunction


subject: CHEBI:136037

object_name: Adrenal hyperfunction


subject: CHEBI:5312

subject_name: gentamicin sulfate

object_name: junctional epidermolysis bullosa


subject: UNII:8X7386QRLV

subject_name: GENTAMICIN SULFATE


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin


subject: UMLS:C0086466

subject_name: Injectables


subject: UMLS:C0017132

subject_name: Gastric Inhibitory Polypeptide

object_name: type 1 diabetes mellitus


subject: CHEBI:80165


subject: CHEBI:15570

subject_name: D-Alanine


subject: CHEBI:46217

subject_name: L-alanine residue


subject: CHEBI:16449

subject_name: DL-Alanine


subject: CHEBI:16977

subject_name: Alanine


subject: CHEBI:17303

subject_name: Morphine

object_name: obstructive sleep apnea syndrome


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: allergic asthma


subject: UMLS:C5848866

object_name: Allergic rhinoconjunctivitis


subject: UNII:JAC34RRR7S

subject_name: LONDAMOCITINIB

object_name: asthma


subject: CHEBI:31355

subject_name: Carboplatin

object_name: prostate carcinoma


subject: CHEBI:31355

object_name: prostate cancer


subject: CHEBI:63584

subject_name: Cabazitaxel


subject: CHEBI:63584


subject: UNII:5W6YA9PKKH

subject_name: INDINAVIR

object_name: classic Kaposi sarcoma


subject: CHEBI:44032

subject_name: Indinavir


subject: UMLS:C0445115

subject_name: Normal saline

object_name: diabetic neuropathy


subject: CHEBI:94531

subject_name: belinostat

object_name: adult lymphoma


subject: CHEBI:94531

object_name: lymphoma


subject: CHEBI:94531

object_name: pediatric lymphoma


subject: CHEBI:100241

subject_name: Ciprofloxacin


subject: CHEBI:100241


subject: CHEBI:100241


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED


subject: UMLS:C0812735


subject: UMLS:C0812735


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:46081


subject: CHEBI:46081


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Plasma cell myeloma refractory


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: bronchial alveolar; tumor


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721495

subject_name: Astugenal


subject: PUBCHEM.COMPOUND:138115120

subject_name: Taspoglutide

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:138115120

object_name: maturity-onset diabetes of the young type 1


subject: CHEMBL.COMPOUND:CHEMBL2107860

subject_name: TASPOGLUTIDE


subject: CHEMBL.COMPOUND:CHEMBL2107860


subject: UMLS:C2716826

subject_name: taspoglutide


subject: UMLS:C2716826


subject: PUBCHEM.COMPOUND:152165

object_name: chronic pain (diagnosis)


subject: PUBCHEM.COMPOUND:152165

object_name: Chronic pain


subject: PUBCHEM.COMPOUND:152165

object_name: Elbow pain


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:47381


subject: CHEBI:47381


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:75722


subject: CHEBI:75722


subject: CHEBI:38940

subject_name: Sunitinib

object_name: breast neoplasm


subject: MESH:C518471

subject_name: silybin-phytosome

object_name: non-small cell lung carcinoma


subject: CHEBI:134716

subject_name: Brexpiprazole

object_name: borderline personality disorder


subject: UMLS:C5705073

subject_name: NeuroVax

object_name: multiple sclerosis


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: coronary artery disorder


subject: UNII:LKC0U3A8NJ

object_name: coronary atherosclerosis


subject: UNII:LKC0U3A8NJ

object_name: HIV infection


subject: UNII:I5I8VB78VT

subject_name: Erenumab

object_name: Status Migrainosus


subject: CHEBI:145371

subject_name: Binimetinib

object_name: biliary tract neoplasm


subject: UNII:8L7891MRB6

subject_name: Encorafenib


subject: UNII:4B93MGE4AL

subject_name: Futibatinib


subject: PUBCHEM.COMPOUND:78140854

subject_name: Ivosidenib


subject: CHEBI:61397

subject_name: Neratinib


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: GTOPDB:13627

subject_name: zanidatamab


subject: UNII:Z20OC92TDI

subject_name: ZANIDATAMAB


subject: UMLS:C4331966


subject: UMLS:C5555572

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5555572

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5555572

object_name: Ewing sarcoma


subject: UMLS:C5555572

object_name: Stomach cancer


subject: UMLS:C5555572

object_name: gastric cancer


subject: UMLS:C5555572

object_name: colorectal cancer


subject: UMLS:C5555572

object_name: colorectal carcinoma


subject: UMLS:C5555572

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:11670360

subject_name: Nirogacestat

object_name: Unresectable Desmoid Fibromatosis


subject: PUBCHEM.COMPOUND:11670360

object_name: Recurrent Desmoid Fibromatosis


subject: CHEBI:36791

subject_name: Escitalopram

object_name: mal de Debarquement


subject: CHEBI:36791

object_name: Minimal Disseminated Disease


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: CHEBI:174315

subject_name: Cocaethylene

object_name: cocaine abuse


subject: UMLS:C2830125

object_name: leukemia


subject: UMLS:C2830125

object_name: childhood leukemia


subject: CHEBI:145371


subject: CHEBI:145371


subject: CHEBI:52172

subject_name: Nilotinib


subject: CHEBI:52172


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Stage I Fallopian Tube Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage I Fallopian Tube Cancer


subject: CHEBI:31355

object_name: Stage II Fallopian Tube Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage II Fallopian Tube Cancer


subject: CHEBI:31355

object_name: Stage III Fallopian Tube Cancer AJCC v6


subject: CHEBI:31355

object_name: Stage III Fallopian Tube Cancer AJCC v7


subject: CHEBI:31355

object_name: Stage III Fallopian Tube Cancer AJCC v8


subject: CHEBI:31355

object_name: Ovarian epithelial cancer stage II


subject: CHEBI:31355

object_name: Stage I Ovarian Cancer AJCC v6 and v7


subject: CHEBI:64019

subject_name: Nebivolol

object_name: coronary microvascular disorder


subject: CHEBI:64019

object_name: obstructive sleep apnea syndrome


subject: CHEBI:88353

subject_name: Bryostatin 1

object_name: carcinoma of esophagus


subject: CHEBI:88353

object_name: esophageal cancer


subject: CHEBI:88353

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:88353

object_name: neoplasm of esophagus


subject: CHEBI:88353

object_name: Stomach cancer


subject: CHEBI:88353

object_name: gastric cancer


subject: CHEBI:91594


subject: CHEBI:91594


subject: CHEBI:91594


subject: CHEBI:91594


subject: CHEBI:91594


subject: CHEBI:91594


subject: UMLS:C0678133

subject_name: Taxol


subject: UMLS:C0678133


subject: UMLS:C0678133


subject: UMLS:C0678133


subject: UMLS:C0678133


subject: UMLS:C0678133


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Childhood Breast Carcinoma


subject: GTOPDB:12989

object_name: breast carcinoma


subject: GTOPDB:12989

object_name: breast cancer


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: CHEBI:8382

subject_name: Prednisone

object_name: prostate neoplasm


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:8774

subject_name: Ramipril

object_name: diabetes mellitus


subject: CHEBI:42797

subject_name: Gabapentin

object_name: no feeling or sensation of skin


subject: CHEBI:42797

object_name: Sensory Loss


subject: CHEBI:42797

object_name: urethral obstruction


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: interstitial lung disease


subject: CHEBI:28939

object_name: Rheumatism


subject: CHEBI:28939

object_name: connective tissue disorder


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:14907381

object_name: lymphoma


subject: PUBCHEM.COMPOUND:14907381

object_name: pediatric lymphoma


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:45081

subject_name: Pentamidine


subject: CHEBI:45081


subject: CHEBI:45081


subject: CHEBI:3770

subject_name: co-trimoxazole


subject: CHEBI:3770


subject: CHEBI:3770


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0919075

subject_name: INJECTION, ZIDOVUDINE, 10 MG ADMINISTERED


subject: UMLS:C0919075


subject: UMLS:C0919075


subject: CHEBI:10110

subject_name: Zidovudine


subject: CHEBI:10110


subject: CHEBI:10110


subject: CHEBI:161680

subject_name: Aztreonam


subject: CHEBI:161680


subject: CHEBI:161680


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: HIV infection


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:71223

subject_name: Pralatrexate

object_name: Solid Neoplasm


subject: CHEBI:125400

subject_name: actinomycin D

object_name: adult kidney Wilms tumor


subject: CHEBI:125400

object_name: Stage V Kidney Wilms Tumor


subject: CHEBI:125400

object_name: childhood kidney Wilms tumor


subject: CHEBI:125400

object_name: Diffuse Hyperplastic Perilobar Nephroblastomatosis


subject: CHEBI:125400

object_name: Perlman syndrome


subject: CHEBI:125400

object_name: Beckwith-Wiedemann syndrome


subject: CHEBI:27666

subject_name: Dactinomycin


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:78538

object_name: osteoarthritis, knee


subject: CHEBI:77323

subject_name: Ethoxyquin

object_name: pancreatitis


subject: CHEBI:77323

object_name: Pancreatitis, CTCAE 5.0


subject: CHEBI:77323

object_name: Pancreatitis, CTCAE 3.0


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism


subject: UMLS:C3540792


subject: UMLS:C3540792


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:18420


subject: CHEBI:18420


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C3714621


subject: UMLS:C3714621


subject: PUBCHEM.COMPOUND:132451761

subject_name: Forteo

object_name: osteoporosis


subject: PUBCHEM.COMPOUND:132451761

object_name: Encounter due to family history of osteoporosis


subject: PUBCHEM.COMPOUND:132451761

object_name: Osteoporosis, CTCAE 5.0


subject: PUBCHEM.COMPOUND:132451761

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C0376564


subject: UMLS:C0376564


subject: UMLS:C0376564


subject: UMLS:C0376564


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: Intraoperative hypotension


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: acute myeloid leukemia


subject: UNII:7D0YB67S97

object_name: acute lymphoblastic leukemia


subject: UNII:7D0YB67S97

object_name: Other myelodysplastic syndromes


subject: UNII:7D0YB67S97

object_name: juvenile myelomonocytic leukemia


subject: UNII:7D0YB67S97

object_name: chronic myelomonocytic leukemia


subject: UNII:7D0YB67S97

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:7D0YB67S97

object_name: Myelodysplasia


subject: UNII:7D0YB67S97

object_name: Hodgkin Disease


subject: UNII:7D0YB67S97

object_name: Adult Hodgkin Lymphoma


subject: UNII:7D0YB67S97

object_name: Childhood Hodgkin Lymphoma


subject: UNII:7D0YB67S97

object_name: adult lymphoma


subject: UNII:7D0YB67S97

object_name: lymphoma


subject: UNII:7D0YB67S97

object_name: pediatric lymphoma


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:131174

subject_name: Navitoclax

object_name: refractory malignant neoplasm


subject: CHEBI:131174

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:131174

object_name: Unresectable Solid Neoplasm


subject: CHEBI:131174

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:131174

object_name: Stage IV Hepatocellular Carcinoma AJCC v7


subject: CHEBI:131174

object_name: Recurrent Hepatocellular Carcinoma


subject: CHEBI:131174

object_name: hepatitis B


subject: CHEBI:131174

object_name: hepatitis C


subject: CHEBI:131174

object_name: Cirrhosis


subject: CHEBI:131174

object_name: liver cirrhosis


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: UNII:W6I5QDT7QI

subject_name: Netarsudil

object_name: CAPN5-related vitreoretinopathy


subject: UNII:W6I5QDT7QI

object_name: proliferative vitreoretinopathy


subject: UNII:W6I5QDT7QI

object_name: rhegmatogenous retinal detachment


subject: PUBCHEM.COMPOUND:4240

subject_name: Mometasone furoate

object_name: sickle cell disease


subject: CHEBI:6970

subject_name: Mometasone


subject: UMLS:C5784758

subject_name: Dazukibart

object_name: juvenile dermatomyositis


subject: UMLS:C5784758

object_name: myositis


subject: UMLS:C5784758

object_name: Myositis, CTCAE 5.0


subject: UNII:4NP0CFH7QL

object_name: Stomach cancer


subject: UNII:4NP0CFH7QL

object_name: gastric cancer


subject: UMLS:C4687662

subject_name: Antibody-drug Conjugate SC-007


subject: UMLS:C4687662


subject: CHEBI:71954

subject_name: Buparlisib

object_name: carcinoma of esophagus


subject: CHEBI:71954

object_name: esophageal cancer


subject: CHEBI:71954

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:71954

object_name: neoplasm of esophagus


subject: UNII:5IB2J79MCX

subject_name: Spesolimab

object_name: inflammatory bowel disease 1


subject: UNII:5IB2J79MCX

object_name: Crohn disease


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Angiofibromas


subject: CHEBI:9168

object_name: tuberous sclerosis


subject: CHEBI:9168

object_name: situs inversus


subject: UMLS:C1134528

subject_name: NY-ESO-1 peptide vaccine

object_name: fallopian tube carcinoma


subject: UMLS:C1134528

object_name: fallopian tube cancer


subject: UMLS:C1134528

object_name: ovarian cancer


subject: UMLS:C1134528

object_name: ovarian neoplasm


subject: UMLS:C1134528

object_name: ovarian carcinoma


subject: UMLS:C1134528

object_name: peritoneum cancer


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: Functional disorder


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: CHEBI:17634

subject_name: D-glucose


subject: CHEBI:17234


subject: UMLS:C1327842

subject_name: Hexvix

object_name: bladder tumor


subject: UMLS:C1327842

object_name: urinary bladder carcinoma


subject: UMLS:C1327842

object_name: urinary bladder cancer


subject: UMLS:C1327842

object_name: childhood bladder carcinoma


subject: CHEBI:51368

subject_name: Lofexidine

object_name: Buprenorphine withdrawal


subject: CHEBI:51368

object_name: opiate dependence


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Hyperabduction syndrome


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Advanced Hepatocellular Carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: carcinoma


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: UNII:9Y9727LS4D

subject_name: Turoctocog alfa pegol

object_name: hemophilia A


subject: UNII:9Y9727LS4D

object_name: Congenital Bleeding Disorder


subject: CHEBI:67272

subject_name: Perifosine

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:67272

object_name: clear cell renal carcinoma


subject: CHEBI:67272

object_name: renal cell adenocarcinoma


subject: CHEBI:67272

object_name: renal cell carcinoma


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: pancreatic adenocarcinoma


subject: UMLS:C4054250


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: non-small cell lung carcinoma


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:8378

subject_name: Prednisolone

object_name: plasma cell myeloma


subject: UNII:91X1KLU43E

subject_name: Golimumab

object_name: juvenile idiopathic arthritis


subject: UMLS:C3896849

object_name: acute myeloid leukemia


subject: UMLS:C5706432

subject_name: WT1-targeted IL-2-based Fusion Protein CUE-102

object_name: glioblastoma


subject: UMLS:C5706432

object_name: Childhood Glioblastoma


subject: UMLS:C5706432

object_name: adult glioblastoma


subject: UMLS:C5706432

object_name: Recurrent Childhood Glioblastoma


subject: UMLS:C5706432

object_name: Recurrent Glioblastoma


subject: UMLS:C5706432

object_name: malignant glioma


subject: CHEBI:58097

object_name: Postoperative Complications


subject: CHEBI:17303

subject_name: Morphine


subject: PUBCHEM.COMPOUND:134129840

subject_name: POLYMYXIN B

object_name: Cross Infection


subject: PUBCHEM.COMPOUND:4868

subject_name: polymyxin B


subject: CHEMBL.COMPOUND:CHEMBL5314354


subject: UMLS:C4086907

object_name: melanoma


subject: UMLS:C5238067

subject_name: Garadacimab

object_name: hereditary angioedema


subject: CHEBI:23965

subject_name: estradiol

object_name: Postmenopausal


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Seizure Related to COVID-19


subject: PUBCHEM.COMPOUND:4715169

object_name: epilepsy


subject: PUBCHEM.COMPOUND:4715169

object_name: visual epilepsy


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: CHEBI:64356


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Behcet's syndrome, vascular type


subject: CHEBI:4026

object_name: aneurysm


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UNII:I031V2H011


subject: CHEBI:71200

subject_name: Tofacitinib


subject: CHEBI:71200


subject: PR:000001945

subject_name: transferrin receptor protein 1

object_name: cancer


subject: PR:000001945

object_name: neoplasm


subject: PR:000001945

object_name: malnutrition


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox

object_name: Stomach cancer


subject: PUBCHEM.COMPOUND:135659064

object_name: gastric cancer


subject: CHEBI:27928

subject_name: parathion


subject: CHEBI:27928


subject: PR:000030981

subject_name: proton-activated chloride channel


subject: PR:000030981


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: graft versus host disease


subject: UMLS:C0378942


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: retrograde cricopharyngeus dysfunction


subject: CHEBI:114785

subject_name: Erlotinib

object_name: primary peritoneal carcinoma


subject: CHEBI:114785

object_name: Primary Peritoneal Cancer


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: neuroendocrine carcinoma


subject: CHEBI:72564

subject_name: Temozolomide


subject: UNII:37KZM6S21G

subject_name: cerebrolysin

object_name: Acute Ischemic Stroke


subject: UNII:37KZM6S21G

object_name: Ischemic stroke


subject: UMLS:C0055108


subject: UMLS:C0055108


subject: PUBCHEM.COMPOUND:9916099

subject_name: Letermovir

object_name: Infection of transplanted kidney


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: brain neoplasm


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: Helicobacter pylori infection


subject: CHEBI:63598

subject_name: Levofloxacin


subject: UMLS:C0675788

subject_name: Eovist

object_name: liver cancer


subject: UMLS:C0675788

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:94559

subject_name: Levocetirizine

object_name: rhinitis


subject: CHEMBL.COMPOUND:CHEMBL4650405

subject_name: LERODALCIBEP

object_name: cardiovascular disorder


subject: CHEMBL.COMPOUND:CHEMBL4650405

object_name: Hypercholesterolemia


subject: UMLS:C5446762

subject_name: Lerodalcibep


subject: UMLS:C5446762


subject: UNII:9K8GNJ2874

subject_name: Naxitamab

object_name: Neuroblastoma recurrent


subject: UMLS:C4054758

subject_name: naxitamab


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Stage III Primary Peritoneal Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Primary Peritoneal Transitional Cell Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage II Fallopian Tube Cancer


subject: UNII:2S9ZZM9Q9V

object_name: Primary Peritoneal Undifferentiated Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Clear cell adenocarcinoma of peritoneum


subject: UNII:2S9ZZM9Q9V

object_name: Ovarian epithelial cancer stage II


subject: UNII:2S9ZZM9Q9V

object_name: Undifferentiated Fallopian Tube Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: fallopian tube clear cell adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: fallopian tube serous adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Primary Peritoneal Endometrioid Adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: ovarian clear cell adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: malignant ovarian Brenner tumor


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767

object_name: Ovarian cancer stage III


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Clear cell adenocarcinoma of peritoneum


subject: PUBCHEM.COMPOUND:2767

object_name: primary peritoneal serous adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: peritoneal serous adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Ovarian epithelial cancer stage II


subject: PUBCHEM.COMPOUND:2767

object_name: Undifferentiated Fallopian Tube Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: fallopian tube clear cell adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: fallopian tube transitional cell carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: ovarian transitional cell carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: fallopian tube mucinous adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: fallopian tube serous adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Primary Peritoneal Endometrioid Adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: ovarian seromucinous carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: fallopian tube endometrioid adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: undifferentiated ovarian carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: ovarian clear cell adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: ovarian serous adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Primary mucinous adenocarcinoma of ovary


subject: PUBCHEM.COMPOUND:2767

object_name: ovarian mucinous adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: malignant ovarian Brenner tumor


subject: PUBCHEM.COMPOUND:2767

object_name: ovarian endometrioid adenocarcinoma


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Stage III Primary Peritoneal Cancer AJCC v7


subject: CHEBI:45863

object_name: Primary Peritoneal Transitional Cell Carcinoma


subject: CHEBI:45863

object_name: Stage II Fallopian Tube Cancer


subject: CHEBI:45863

object_name: Primary Peritoneal Undifferentiated Carcinoma


subject: CHEBI:45863

object_name: Clear cell adenocarcinoma of peritoneum


subject: CHEBI:45863

object_name: Ovarian epithelial cancer stage II


subject: CHEBI:45863

object_name: Undifferentiated Fallopian Tube Carcinoma


subject: CHEBI:45863

object_name: fallopian tube clear cell adenocarcinoma


subject: CHEBI:45863

object_name: fallopian tube serous adenocarcinoma


subject: CHEBI:45863

object_name: Primary Peritoneal Endometrioid Adenocarcinoma


subject: CHEBI:45863


subject: CHEBI:45863


subject: UMLS:C4744685

object_name: amyloidosis


subject: UMLS:C4744685

object_name: plasma cell myeloma


subject: CHEBI:33363

subject_name: palladium


subject: CHEBI:33363


subject: CHEBI:74756

subject_name: Pro-Asp


subject: CHEBI:74756


subject: CHEMBL.COMPOUND:CHEMBL3989992

subject_name: PEGILODECAKIN

object_name: pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL3989992

object_name: exocrine pancreatic carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3989992

object_name: malignant pancreatic neoplasm


subject: UMLS:C3827166


subject: UMLS:C3827166


subject: UMLS:C3827166


subject: CHEBI:85083

subject_name: Sofosbuvir

object_name: liver carcinoma


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:16919

subject_name: Creatine

object_name: juvenile dermatomyositis


subject: UMLS:C4725178

subject_name: TAFIa Inhibitor DS-1040b

object_name: Acute Ischemic Stroke


subject: UMLS:C4725178

object_name: Ischemic stroke


subject: UMLS:C4725178

object_name: thrombosis


subject: UNII:W0ZE0NT8IF

subject_name: Etrumadenant

object_name: gastroesophageal cancer


subject: UNII:W0ZE0NT8IF

object_name: colorectal cancer


subject: UNII:W0ZE0NT8IF

object_name: colorectal carcinoma


subject: UNII:W0ZE0NT8IF

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3273936

object_name: non-small cell lung carcinoma


subject: UNII:3CO94WO6DJ

subject_name: Eplivanserin

object_name: Primary Insomnia


subject: UMLS:C3819106

subject_name: Pedia-Lax Probiotic

object_name: Dysbiosis


subject: CHEBI:94573

subject_name: Zibotentan

object_name: kidney failure


subject: CHEBI:94573

object_name: Hepatic impairment


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: type 1 diabetes mellitus 1


subject: CHEBI:46245

object_name: type 1 diabetes mellitus


subject: MESH:D008458

subject_name: Measles Vaccine

object_name: mumps


subject: MESH:D008458

object_name: rubella


subject: MESH:D009108

subject_name: Mumps Vaccine

object_name: measles


subject: MESH:D009108

object_name: chickenpox


subject: MESH:D009108


subject: UMLS:C0035923

subject_name: Rubella Vaccine


subject: UMLS:C0035923


subject: UMLS:C0035923


subject: UMLS:C0035923


subject: MESH:D019433

subject_name: Chickenpox Vaccine


subject: MESH:D019433


subject: PUBCHEM.COMPOUND:25110515

subject_name: Ozanimod

object_name: inflammatory bowel disease 1


subject: MESH:C000620181

object_name: pancreatic neoplasm


subject: UMLS:C3273454


subject: CHEBI:33942

subject_name: ribose

object_name: heart failure


subject: CHEBI:33942

object_name: congestive heart failure


subject: CHEBI:47013

subject_name: D-ribofuranose


subject: CHEBI:47013


subject: CHEBI:16988

subject_name: D-ribose


subject: CHEBI:16988


subject: UMLS:C5564711

object_name: Overweight or obesity


subject: UMLS:C5197986

object_name: Drug-induced hyperglycemia


subject: CHEBI:18248

subject_name: Iron

object_name: Celiac disease in children


subject: CHEBI:29034

subject_name: Ferric cation


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: CHEBI:28793

subject_name: beta-D-glucan

object_name: Prediabetes


subject: CHEBI:28793

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:28793

object_name: obesity


subject: CHEBI:28793

object_name: Obesity, CTCAE


subject: DRUGBANK:DB19271

subject_name: Yeast beta-D-glucan


subject: DRUGBANK:DB19271


subject: DRUGBANK:DB19271


subject: DRUGBANK:DB19271


subject: MESH:D000084922

subject_name: Resistant Starch


subject: MESH:D000084922


subject: MESH:D000084922


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Platinum-Refractory Ovarian Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: suppressor of tumorigenicity 3


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: nonpapillary renal cell carcinoma


subject: PUBCHEM.COMPOUND:135423438

object_name: clear cell renal carcinoma


subject: PUBCHEM.COMPOUND:135423438

object_name: renal cell adenocarcinoma


subject: PUBCHEM.COMPOUND:135423438

object_name: renal cell carcinoma


subject: PUBCHEM.COMPOUND:135423438

object_name: colorectal adenocarcinoma


subject: PUBCHEM.COMPOUND:135423438


subject: PUBCHEM.COMPOUND:135423438


subject: PUBCHEM.COMPOUND:135423438

object_name: cervical carcinoma


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: UMLS:C1710381

subject_name: Circadin

object_name: Primary Insomnia


subject: CHEBI:16796

subject_name: Melatonin


subject: UNII:2HLC17MX9G

subject_name: Agalsidase alfa

object_name: Fabry disease


subject: CHEBI:132082

subject_name: Entinostat

object_name: Hodgkin Disease


subject: CHEMBL.COMPOUND:CHEMBL5314673

subject_name: EMPASIPRUBART

object_name: multifocal motor neuropathy


subject: UMLS:C5783744

subject_name: Empasiprubart


subject: DRUGBANK:DB10543

subject_name: Cow milk

object_name: Inflammation


subject: DRUGBANK:DB10543

object_name: Increased reactive oxygen species production


subject: CHEBI:75922

subject_name: Nepafenac

object_name: background diabetic retinopathy


subject: CHEBI:49325

subject_name: oral contraceptive

object_name: retained products of conception post abortion


subject: UMLS:C0009905

subject_name: Contraceptives, Oral


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: Insulin resistance


subject: CHEBI:17460

subject_name: Thioctamide

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:17460

object_name: obesity


subject: CHEBI:17460

object_name: Obesity, CTCAE


subject: CHEBI:17460

object_name: type 2 diabetes mellitus


subject: CHEBI:17460


subject: CHEBI:16494

subject_name: thioctic acid


subject: UMLS:C0728965

subject_name: Triphasil

object_name: HIV infection


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: High Risk Myelodysplastic Syndrome


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:95044

subject_name: Tosedostat


subject: CHEBI:95044

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:95044

object_name: acute myeloid leukemia


subject: UMLS:C5784892

subject_name: Anti-CEA/Anti-4-1BB Bispecific Antibody BGB-B167

object_name: Childhood Solid Neoplasm


subject: UMLS:C5784892

object_name: Adult Solid Neoplasm


subject: UMLS:C5784892

object_name: Solid Neoplasm


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C2825464

subject_name: metafolin

object_name: Uses contraception (finding)


subject: CHEMBL.COMPOUND:CHEMBL4298180

subject_name: DARVADSTROCEL

object_name: Crohn disease


subject: UMLS:C5227825

subject_name: Darvadstrocel


subject: CHEBI:8863

subject_name: Riluzole

object_name: Osteochondritis


subject: CHEBI:8863


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: Acne inversa


subject: UMLS:C5960313

subject_name: STAT3 Dual Phosphorylation Site Inhibitor YY201

object_name: benign prostatic hyperplasia


subject: CHEBI:64312

subject_name: Memantine

object_name: bipolar disorder


subject: CHEBI:31536

subject_name: Emtricitabine

object_name: Acute HIV infection


subject: UMLS:C3896882

subject_name: PI3K/mTORC1/mTORC2 Inhibitor DCBCI0901

object_name: cancer


subject: UMLS:C3896882

object_name: neoplasm


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: chronic hepatitis B virus infection


subject: CHEBI:47097

subject_name: Lonafarnib

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C0759338


subject: UMLS:C0009871

subject_name: Contraceptive Agents


subject: UMLS:C0009871

object_name: pregnancy related


subject: UMLS:C0009871

object_name: Pregnant


subject: CHEBI:6402

subject_name: Leflunomide

object_name: psoriatic arthritis


subject: CHEMBL.COMPOUND:CHEMBL4594330

subject_name: DAXDILIMAB

object_name: alopecia areata


subject: CHEMBL.COMPOUND:CHEMBL4594330

object_name: alopecia


subject: UMLS:C5420897

subject_name: Daxdilimab


subject: UMLS:C5420897


subject: GTOPDB:13718

subject_name: xaluritamig

object_name: prostate carcinoma


subject: GTOPDB:13718

object_name: prostate cancer


subject: UNII:ODG03B9M4U

subject_name: XALURITAMIG


subject: UNII:ODG03B9M4U


subject: UMLS:C5238964

subject_name: Xaluritamig


subject: UMLS:C5238964


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:89324

object_name: Fatigue


subject: CHEBI:89324

object_name: inflammatory bowel disease 1


subject: CHEBI:89324

object_name: disease of bone structure


subject: CHEBI:89324

object_name: Paresis


subject: CHEBI:89324

object_name: Muscle weakness


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C5391658

object_name: hereditary angioedema


subject: UNII:XZA0KB1BDQ

subject_name: Berotralstat


subject: CHEBI:44915

subject_name: Propofol

object_name: Mechanical ventilation finding


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: hepatitis C


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: severe acute respiratory syndrome


subject: CHEBI:27300


subject: UMLS:C4745242

subject_name: Anti-PD-L1/TIM-3 Bispecific Antibody LY3415244

object_name: Childhood Solid Neoplasm


subject: UMLS:C4745242

object_name: Adult Solid Neoplasm


subject: UMLS:C4745242

object_name: Solid Neoplasm


subject: PR:000004517

subject_name: aurora kinase B

object_name: opiate dependence


subject: PR:000004517

object_name: Poisoning by methadone


subject: PR:000004517

object_name: cannabis abuse


subject: CHEBI:205919

subject_name: Clobetasol

object_name: psoriasis


subject: CHEBI:72296

subject_name: Apixaban

object_name: acute lymphoblastic leukemia


subject: CHEBI:72296

object_name: adult lymphoma


subject: CHEBI:72296

object_name: lymphoma


subject: CHEBI:72296

object_name: pediatric lymphoma


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: Adverse effect of radiation therapy


subject: UNII:15C2VL427D

object_name: Disorder due to radiotherapy


subject: CHEMBL.COMPOUND:CHEMBL5314673

subject_name: EMPASIPRUBART

object_name: chronic inflammatory demyelinating polyradiculoneuropathy


subject: CHEMBL.COMPOUND:CHEMBL5314673

object_name: Guillain-Barre syndrome, familial


subject: CHEMBL.COMPOUND:CHEMBL5314673

object_name: polyneuropathy, inflammatory demyelinating, chronic


subject: UMLS:C5783744

subject_name: Empasiprubart


subject: UMLS:C5783744


subject: UMLS:C5783744


subject: UMLS:C0076726

subject_name: Tissue Kallikrein

object_name: cerebrovascular disorder


subject: PR:000009406


subject: MESH:C000709210


subject: CHEBI:17710

subject_name: Mevalonic acid

object_name: smallpox


subject: CHEBI:17710

object_name: atopic eczema


subject: DRUGBANK:DB15483

subject_name: Modified vaccinia ankara


subject: DRUGBANK:DB15483


subject: MESH:D012900

subject_name: Smallpox Vaccine


subject: MESH:D012900


subject: CHEMBL.COMPOUND:CHEMBL2108688

subject_name: SMALLPOX VACCINE


subject: CHEMBL.COMPOUND:CHEMBL2108688


subject: UMLS:C2700141

subject_name: vaccinia virus strain New York City Board of Health live antigen


subject: UMLS:C2700141


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Neonatal effect NOS


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:76978

subject_name: Tricaprylin

object_name: Age-associated memory impairment


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: irritable bowel syndrome


subject: CHEBI:8863

subject_name: Riluzole

object_name: fragile X syndrome


subject: CHEBI:73611

subject_name: Met-Gly

object_name: schizophrenia


subject: CHEBI:73611

object_name: psychosis


subject: CHEBI:73611

object_name: Nonorganic psychosis


subject: CHEBI:73611

object_name: Psychosis, CTCAE


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:25107


subject: PR:000004501

subject_name: attractin


subject: PR:000004501


subject: PR:000004501


subject: PR:000004501


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UMLS:C0487173


subject: UMLS:C0487173


subject: UMLS:C0487173


subject: CHEBI:28918

subject_name: Epinephrine

object_name: anaphylaxis


subject: UMLS:C4056500

subject_name: soluble corn fiber

object_name: osteoporosis


subject: UMLS:C4056500

object_name: Encounter due to family history of osteoporosis


subject: UMLS:C4056500

object_name: Osteoporosis, CTCAE 5.0


subject: UMLS:C4056500

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C3661179

object_name: osteoarthritis, knee


subject: UMLS:C5706517

subject_name: Anti-CD20/CD37 Monoclonal Antibody Combination PSB202

object_name: Indolent Non-Hodgkin Lymphoma


subject: UMLS:C5706517

object_name: Indolent lymphoma


subject: UMLS:C5706517

object_name: B-cell lymphoma refractory


subject: UMLS:C5706517

object_name: chronic lymphocytic leukemia/small lymphocytic lymphoma


subject: UMLS:C5706517

object_name: mantle cell lymphoma


subject: UMLS:C5706517

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C5706517

object_name: marginal zone lymphoma


subject: UMLS:C5706517

object_name: MALT lymphoma


subject: UMLS:C5706517

object_name: follicular lymphoma


subject: UMLS:C4077912

object_name: type 2 diabetes mellitus


subject: CHEBI:10119

subject_name: Ziprasidone


subject: UNII:0JSR7Z0NB6

subject_name: Amivantamab

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4085970


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab


subject: UMLS:C3827082


subject: UNII:4B93MGE4AL

subject_name: Futibatinib


subject: UMLS:C0872996

subject_name: Q fever vaccine

object_name: Q fever


subject: UMLS:C5240158

subject_name: Vaccine product containing only Coxiella burnetii antigen (medicinal product)


subject: UMLS:C5238974

object_name: Childhood Breast Carcinoma


subject: UMLS:C5238974

object_name: breast carcinoma


subject: UMLS:C5238974

object_name: breast cancer


subject: UMLS:C5238974

object_name: prostate carcinoma


subject: UMLS:C5238974

object_name: prostate cancer